A carregar...
Nitric Oxide–Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation
Nitric oxide (NO)–releasing agents such as JS-K and NO–releasing hybrids such as NO– and NONO–nonsteroidal anti-inflammatory drugs are novel agents with great potential for controlling cancer. Although studied extensively, a key question pertaining to their molecular targets and mechanism of action...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666189/ https://ncbi.nlm.nih.gov/pubmed/23730526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/ForumImmunDisTher.2012006099 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|